The FDA provided Schering-Plough Pharmaceuticals with approval to sell Claritin without a prescription.
Claritin is the first non-sedating antihistamine to receive FDA approval for sale over-the-counter. The non-prescription Claritin is the same strength and dosage as the prescription product. This move to non-prescription includes all currently manufactured strengths and dosage forms of Claritin, Claritin-D and Children's Claritin Syrup.
Your plan will no longer cover Claritin under the prescription drug benefit. Therefore, any Claritin prescription claims submitted will reject as non-covered. Note that the expense for OTC Claritin may be more than a co-pay amount.
If you are an employee who utilizes Claritin, contact your individual physician or pharmacist for recommendations or advice related to your care.
